[Federal Register Volume 64, Number 72 (Thursday, April 15, 1999)]
[Rules and Regulations]
[Pages 18572-18573]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-9455]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 520
Oral Dosage Form New Animal Drugs; Omeprazole
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of a new animal drug application
(NADA) filed by Merial Ltd. The NADA provides for oral use of
omeprazole for the treatment and prevention of recurrence of gastric
ulcers in horses and foals 4 weeks of age and older.
EFFECTIVE DATE: April 15, 1999.
FOR FURTHER INFORMATION CONTACT: Melanie R. Berson, Center for
Veterinary Medicine (HFV-110), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855, 301-827-7543.
SUPPLEMENTARY INFORMATION: Merial Ltd., 2100 Ronson Rd., Iselin, NJ
08830-3077, filed NADA 141-123 that provides for oral, veterinary
prescription use of GastroGard (omeprazole) oral paste for
horses and foals 4 weeks of age and older for the treatment and
prevention of recurrence of gastric ulcers. The NADA is approved as of
March 16, 1999, and the regulations are amended by adding 21 CFR
520.1615 to reflect the approval. The basis of approval is discussed in
the freedom of information summary.
In accordance with the freedom of information provisions of 21 CFR
part 20 and 514.11(e)(2)(ii), a summary of safety and effectiveness
data and information submitted to support approval of this application
may be seen in the Dockets Management Branch (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852,
between 9 a.m. and 4 p.m., Monday through Friday.
Under section 512 of the Federal, Food, Drug and Cosmetic Act (the
act) (21 U.S.C. 360b(c)(2)(F)(i)), this approval qualifies for 5 years
of marketing exclusivity beginning March 16, 1999, because no active
ingredient
[[Page 18573]]
(including any ester or salt thereof) has been previously approved in
any other application filed under section 512(b)(1) of the act.
The agency has determined under 21 CFR 25.33(d)(1) that this
action is of a type that does not individually or cumulatively have a
significant effect on the human environment. Therefore, neither an
environmental assessment nor an environmental impact statement is
required.
List of Subjects in 21 CFR Part 520
Animal drugs.
Therefore, under the Federal Food, Drug, and Cosmetic Act and
under authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is
amended as follows:
PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS
1. The authority citation for 21 CFR part 520 continues to read as
follows:
Authority: 21 U.S.C. 360b.
2. Section 520.1615 is added to read as follows:
Sec. 520.1615 Omeprazole.
(a) Specifications. Each gram of oral paste contains 0.37 gram of
omeprazole.
(b) Sponsor. See No. 050604 in Sec. 510.600(c) of this chapter.
(c) [Reserved]
(d) Conditions of use--(1) Amount. For treatment of gastric
ulcers, 1.8 milligrams of omeprazole per pound of body weight (4
milligrams per kilogram) once daily for 4 weeks. For prevention of
recurrence of gastric ulcers, 0.9 milligram of omeprazole per pound of
body weight (2 milligrams per kilogram) once daily for at least an
additional 4 weeks.
(2) Indications for use. For treatment and prevention of
recurrence of gastric ulcers in horses and foals 4 weeks of age and
older.
(3) Limitations. Do not use in horses intended for human
consumption. Federal law restricts this drug to use by or on the order
of a licensed veterinarian.
Dated: April 1, 1999.
George A. Mitchell,
Acting Director, Center for Veterinary Medicine.
[FR Doc. 99-9455 Filed 4-14-99; 8:45 am]
BILLING CODE 4160-01-F
